Genetic Non-Discrimination Hearing Committee On

Genetic Non-Discrimination Hearing Committee On

GENETIC NON-DISCRIMINATION HEARING BEFORE THE SUBCOMMITTEE ON HEALTH OF THE COMMITTEE ON WAYS AND MEANS U.S. HOUSE OF REPRESENTATIVES ONE HUNDRED TENTH CONGRESS FIRST SESSION MARCH 14, 2007 Serial No. 110–22 Printed for the use of the Committee on Ways and Means ( U.S. GOVERNMENT PRINTING OFFICE 47–006 WASHINGTON : 2009 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2104 Mail: Stop IDCC, Washington, DC 20402–0001 VerDate Nov 24 2008 03:04 Apr 09, 2009 Jkt 047006 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 E:\HR\OC\A006A.XXX A006A jbell on PRODPC61 with HEARING COMMITTEE ON WAYS AND MEANS CHARLES B. RANGEL, New York, Chairman FORTNEY PETE STARK, California JIM MCCRERY, Louisiana SANDER M. LEVIN, Michigan WALLY HERGER, California JIM MCDERMOTT, Washington DAVE CAMP, Michigan JOHN LEWIS, Georgia JIM RAMSTAD, Minnesota RICHARD E. NEAL, Massachusetts SAM JOHNSON, Texas MICHAEL R. MCNULTY, New York PHIL ENGLISH, Pennsylvania JOHN S. TANNER, Tennessee JERRY WELLER, Illinois XAVIER BECERRA, California KENNY HULSHOF, Missouri LLOYD DOGGETT, Texas RON LEWIS, Kentucky EARL POMEROY, North Dakota KEVIN BRADY, Texas STEPHANIE TUBBS JONES, Ohio THOMAS M. REYNOLDS, New York MIKE THOMPSON, California PAUL RYAN, Wisconsin JOHN B. LARSON, Connecticut ERIC CANTOR, Virginia RAHM EMANUEL, Illinois JOHN LINDER, Georgia EARL BLUMENAUER, Oregon DEVIN NUNES, California RON KIND, Wisconsin PAT TIBERI, Ohio BILL PASCRELL, JR., New Jersey JON PORTER, Nevada SHELLEY BERKLEY, Nevada JOSEPH CROWLEY, New York CHRIS VAN HOLLEN, Maryland KENDRICK MEEK, Florida ALLYSON Y. SCHWARTZ, Pennsylvania ARTUR DAVIS, Alabama JANICE MAYS, Chief Counsel and Staff Director BRETT LOPER, Minority Staff Director SUBCOMMITTEE ON HEALTH FORTNEY PETE STARK, California, Chairman LLOYD DOGGETT, Texas DAVE CAMP, Michigan MIKE THOMPSON, California SAM JOHNSON, Texas RAHM EMANUEL, Illinois JIM RAMSTAD, Minnesota XAVIER BECERRA, California PHIL ENGLISH, Pennsylvania EARL POMEROY, North Dakota KENNY HULSHOF, Missouri STEPHANIE TUBBS JONES, Ohio RON KIND, Wisconsin Pursuant to clause 2(e)(4) of Rule XI of the Rules of the House, public hearing records of the Committee on Ways and Means are also, published in electronic form. The printed hearing record remains the official version. Because electronic submissions are used to prepare both printed and electronic versions of the hearing record, the process of converting between various electronic formats may introduce unintentional errors or omissions. Such occur- rences are inherent in the current publication process and should diminish as the process is further refined. ii VerDate Nov 24 2008 03:04 Apr 09, 2009 Jkt 047006 PO 00000 Frm 00002 Fmt 0486 Sfmt 0486 E:\HR\OC\A006A.XXX A006A jbell on PRODPC61 with HEARING C O N T E N T S Page Advisory of March 7, 2007, announcing the hearing ............................................ 2 WITNESSES Francis S. Collins, M.D., Ph.D., Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland ......................... 5 Karen Pollitz, Project Director, Georgetown University Health Policy Insti- tute ........................................................................................................................ 28 Sharon Terry, M.A., President and Chief Executive Officer, Genetic Alliance .. 47 David Escher, Former Employee of Burlington Northern Santa Fe Railroad, Reno, Nevada ........................................................................................................ 60 William Corwin, M.D., Medical Director, Clinical Policy, Harvard Pilgrim Health Care, Worcester, Massachusetts, on behalf of America’s Health In- surance Plans ....................................................................................................... 68 iii VerDate Nov 24 2008 03:04 Apr 09, 2009 Jkt 047006 PO 00000 Frm 00003 Fmt 0486 Sfmt 0486 E:\HR\OC\A006A.XXX A006A jbell on PRODPC61 with HEARING VerDate Nov 24 2008 03:04 Apr 09, 2009 Jkt 047006 PO 00000 Frm 00004 Fmt 0486 Sfmt 0486 E:\HR\OC\A006A.XXX A006A jbell on PRODPC61 with HEARING GENETIC NON-DISCRIMINATION WEDNESDAY, MARCH 14, 2007 U.S. HOUSE OF REPRESENTATIVES, COMMITTEE ON WAYS AND MEANS, SUBCOMMITTEE ON HEALTH, Washington, DC. The Subcommittee met, pursuant to notice, at 2:13 p.m., in Room B318, Rayburn House Office Building, the Honorable Fortney Pete Stark (Chairman of the Subcommittee) presiding. [The advisory announcing the hearing follows:] (1) VerDate Nov 24 2008 03:04 Apr 09, 2009 Jkt 047006 PO 00000 Frm 00005 Fmt 6633 Sfmt 6633 E:\HR\OC\A006A.XXX A006A jbell on PRODPC61 with HEARING 2 ADVISORY FROM THE COMMITTEE ON WAYS AND MEANS SUBCOMMITTEE ON HEALTH FOR IMMEDIATE RELEASE CONTACT: (202) 225–3943 March 07, 2007 HL–5 Subcommittee on Health Chairman Stark Announces a Hearing on Genetic Non-Discrimination House Ways and Means Health Subcommittee Chairman Pete Stark (D–CA) an- nounced today that the Subcommittee on Health will hold a hearing on genetic non- discrimination. The hearing will take place at 2:00 p.m. on Wednesday, March 14, 2007, in Room B–318, Rayburn House Office Building. In view of the limited time available to hear witnesses, oral testimony at this hearing will be from invited witnesses only. However, any individual or organization not scheduled for an oral appearance may submit a written statement for consider- ation by the Committee and for inclusion in the printed record of the hearing. BACKGROUND: One of the most significant scientific accomplishments in history has been se- quencing the human genetic code—a breakthrough that is already transforming the battle against a broad range of medical conditions. As a result, scientists have iden- tified genetic markers for a variety of chronic health conditions, increasing the po- tential for early treatment and prevention. Genetic tests provide information to di- agnose conditions, guide treatment decisions and predict future risk of disease. Alongside these benefits reside concerns about how genetic testing might be used. This threat has deterred the public and the scientific community from taking full advantage of the important opportunities that genetic information affords. Of par- ticular concern is the potential for discrimination. A number of institutions, includ- ing health and life insurance companies, health care providers, blood banks, adop- tion agencies, the military, and schools were reported to have engaged in genetic discrimination against asymptomatic individuals. The lack of a federal policy protecting genetic information has resulted in both actual and perceived acts of discrimination. It has also encouraged inconsistent legal responses to grievances associated with such discrimination. As the tax writing au- thority for the U.S. Congress, the Ways and Means Committee can enforce federal insurance laws that apply to ERISA plans, which provide health benefits to the vast majority of Americans. In addition, the Committee has jurisdiction over federal laws relating to Medigap policies. In announcing the hearing, Chairman Stark said, ‘‘No one should face dis- crimination in employment or be denied health insurance based on their genetic information. In order to ensure that genetic science reaches its full potential, patients need to trust that their information will be protected. Otherwise, people will rightly be reluctant to undergo genetic tests that could save lives.’’ VerDate Nov 24 2008 03:04 Apr 09, 2009 Jkt 047006 PO 00000 Frm 00006 Fmt 6633 Sfmt 6621 E:\HR\OC\A006A.XXX A006A jbell on PRODPC61 with HEARING 3 FOCUS OF THE HEARING: The hearing will focus on the need for a federal policy to protect genetic informa- tion and legislation to achieve this purpose, specifically, the Genetic Information Non Discrimination Act. DETAILS FOR SUBMISSION OF WRITTEN COMMENTS: Please Note: Any person(s) and/or organization(s) wishing to submit for the hear- ing record must follow the appropriate link on the hearing page of the Committee website and complete the informational forms. From the Committee homepage, http://waysandmeans.house.gov, select ‘‘110th Congress’’ from the menu entitled, ‘‘Committee Hearings’’ (http://waysandmeans.house.gov/Hearings.asp?congress=18). Select the hearing for which you would like to submit, and click on the link entitled, ‘‘Click here to provide a submission for the record.’’ Once you have followed the on- line instructions, completing all informational forms and clicking ‘‘submit’’ on the final page, an email will be sent to the address which you supply confirming your interest in providing a submission for the record. You MUST REPLY to the email and ATTACH your submission as a Word or WordPerfect document, in compliance with the formatting requirements listed below, by close of business Wednesday, March 28, 2007. Finally, please note that due to the change in House mail policy, the U.S. Capitol Police will refuse sealed-package deliveries to all House Office Buildings. For questions, or if you encounter technical problems, please call (202) 225–1721. FORMATTING REQUIREMENTS: The Committee relies on electronic submissions for printing the official hearing record. As always, submissions will be included in the record according to the discre- tion of the Committee. The Committee will not alter the content of your submission, but we reserve the right to format it according to our guidelines. Any submission provided to the Committee by a witness, any supplementary materials

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    90 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us